VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $753,478 | -63.7% | 80,414 | -9.9% | 0.00% | -100.0% |
| Q2 2023 | $2,076,685 | 0.0% | 89,243 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,076,685 | +14.4% | 89,243 | +24.4% | 0.00% | 0.0% |
| Q4 2022 | $1,815,864 | -99.9% | 71,745 | +13.5% | 0.00% | 0.0% |
| Q3 2022 | $1,219,094,000 | -39.1% | 63,231 | -19.5% | 0.00% | 0.0% |
| Q2 2022 | $2,001,076,000 | +15.3% | 78,566 | +16.4% | 0.00% | 0.0% |
| Q1 2022 | $1,735,585,000 | -36.3% | 67,480 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $2,723,309,000 | -1.8% | 65,042 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $2,773,050,000 | -7.2% | 63,719 | +0.9% | 0.00% | 0.0% |
| Q2 2021 | $2,986,677,000 | +479.1% | 63,170 | +528.0% | 0.00% | – |
| Q1 2021 | $515,725,000 | +91.4% | 10,059 | 0.0% | 0.00% | – |
| Q4 2020 | $269,380,000 | -93.9% | 10,059 | -92.2% | 0.00% | -100.0% |
| Q3 2020 | $4,403,097,000 | -28.3% | 128,258 | -14.4% | 0.00% | -50.0% |
| Q2 2020 | $6,139,641,000 | – | 149,857 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |